Release Date: 27/08/19 09:31 Summary: Ongoing Disclosure Notice - Peter Karl Christopher Huljich Price Sensitive: No Download Document 101.68KB Download
Webinar: What investors should know about what it takes for ASX-listed companies to get medical developments to market